Physician profile
Wai Leong Foo
NPI 1174785190
$11,882.07
in general payments reported to CMS, 2019-2025
54 companies · $2,112 in 2025
The $2,112 reported for 2025 was more than what 94% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,637 · 2020: $1,604 · 2021: $1,038 · 2022: $1,127 · 2023: $2,227 · 2024: $2,137 · 2025: $2,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,449 · Travel and Lodging: $27.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,448.80 |
| Travel and Lodging | $27.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,875.62 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, Superion Indirect Decompression System |
| Abbott Laboratories | $1,573.95 | 2019-2025 | Proclaim, Eterna, Octrode |
| Abbvie INC. | $1,124.59 | 2021-2025 | |
| Vertos Medical, INC. | $586.17 | 2022-2024 | Mild Device Kit |
| Nevro Corp. | $528.07 | 2019-2024 | Senza |
| Medtronic, INC. | $410.71 | 2022-2025 | Intellis Adaptivestim, Absorbatack, Inceptiv |
| Lundbeck LLC | $372.41 | 2021-2025 | Vyepti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $361.65 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $356.96 | 2019-2025 | Belbuca |
| Saluda Medical Americas, INC. | $307.04 | 2025 | Evoke |
| Amgen INC. | $290.97 | 2019-2025 | Krystexxa, Prolia, Evenity |
| Globus Medical, INC. | $281.65 | 2025 | Senza |
| Pfizer INC. | $244.09 | 2023-2025 | |
| Stimwave Technologies Incorporated | $188.63 | 2020 | |
| Flowonix Medical Incorporated | $174.15 | 2020 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wai Leong Foo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.